Efficacy of unani drug Itrifal-e-Sagheer in the treatment of obesity.

Efficacy of Itrifal-e-Sagheer in Dyslipidaemia: A randomised single blind controlled trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009783

Enrollment

Registered

2017-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dyslipidaemia

Interventions

Intervention1: Itrifal-e-Sagheer: orally 10 gm with water at Bed Time daily for 45 days Control Intervention1: Tab. Abana (Prepared by Himalaya Herbal Health Care): 2 tablets twice a day daily for 45

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed patients of dyslipidaemia 2.Patients of either gender in age group of 20-60 years

Exclusion criteria

Exclusion criteria: 1.Other systemic disorders like DM, liver failure, kidney failure, etc. 2.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Change in subjective parametersTimepoint: 45 DAYS	—

Secondary

Measure	Time frame
Serum Cholesterol Serum triglyceride LDL HDL Timepoint: 45days	—

Countries

India

Contacts

Public ContactMd Anzar Alam

Luqman Unani Medical College Hospital and Research Centre

sazforever23@gmail.com9708299881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026